InterCure Statistics
Total Valuation
InterCure has a market cap or net worth of $75.33 million. The enterprise value is $113.02 million.
Important Dates
The last earnings date was Thursday, May 1, 2025, after market close.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
InterCure has 47.16 million shares outstanding. The number of shares has increased by 0.55% in one year.
| Current Share Class | 47.16M |
| Shares Outstanding | 47.16M |
| Shares Change (YoY) | +0.55% |
| Shares Change (QoQ) | +6.60% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 26.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.15 |
| Forward PS | 0.21 |
| PB Ratio | 0.69 |
| P/TBV Ratio | 1.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.53.
| Current Ratio | 1.73 |
| Quick Ratio | 0.96 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.26 |
Financial Efficiency
Return on equity (ROE) is -17.03% and return on invested capital (ROIC) is -8.71%.
| Return on Equity (ROE) | -17.03% |
| Return on Assets (ROA) | -7.09% |
| Return on Invested Capital (ROIC) | -8.71% |
| Return on Capital Employed (ROCE) | -16.40% |
| Revenue Per Employee | $242,872 |
| Profits Per Employee | -$68,938 |
| Employee Count | 270 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 1.74 |
Taxes
| Income Tax | -3.99M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.35% in the last 52 weeks. The beta is 0.51, so InterCure's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -52.35% |
| 50-Day Moving Average | 1.47 |
| 200-Day Moving Average | 1.67 |
| Relative Strength Index (RSI) | 52.75 |
| Average Volume (20 Days) | 13,734 |
Short Selling Information
The latest short interest is 10,681, so 0.02% of the outstanding shares have been sold short.
| Short Interest | 10,681 |
| Short Previous Month | 26,037 |
| Short % of Shares Out | 0.02% |
| Short % of Float | 0.04% |
| Short Ratio (days to cover) | 1.44 |
Income Statement
In the last 12 months, InterCure had revenue of $65.58 million and -$18.61 million in losses. Loss per share was -$0.41.
| Revenue | 65.58M |
| Gross Profit | 11.55M |
| Operating Income | -24.13M |
| Pretax Income | -15.91M |
| Net Income | -18.61M |
| EBITDA | -21.48M |
| EBIT | -24.13M |
| Loss Per Share | -$0.41 |
Full Income StatementBalance Sheet
The company has $21.59 million in cash and $58.04 million in debt, giving a net cash position of -$36.45 million or -$0.77 per share.
| Cash & Cash Equivalents | 21.59M |
| Total Debt | 58.04M |
| Net Cash | -36.45M |
| Net Cash Per Share | -$0.77 |
| Equity (Book Value) | 109.18M |
| Book Value Per Share | 2.31 |
| Working Capital | 45.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$18.37 million and capital expenditures -$1.20 million, giving a free cash flow of -$19.98 million.
| Operating Cash Flow | -18.37M |
| Capital Expenditures | -1.20M |
| Free Cash Flow | -19.98M |
| FCF Per Share | -$0.42 |
Full Cash Flow StatementMargins
Gross margin is 17.61%, with operating and profit margins of -36.80% and -28.38%.
| Gross Margin | 17.61% |
| Operating Margin | -36.80% |
| Pretax Margin | -36.56% |
| Profit Margin | -28.38% |
| EBITDA Margin | -32.75% |
| EBIT Margin | -36.80% |
| FCF Margin | n/a |